Product Information
TEMOZOLOMIDE 250 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $20.5332 per EA under NDC 16571082151. Its NADAC has been published 57 times since Jul 23, 2025.
FDA first approved this application on Apr 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571082151
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206309FDA Approved
4/27/2016
TE Code
AB
On Market Since
10/4/2022
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 250 MG CAPSULE has been published 57 times since Jul 23, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.5332 per EA |
|---|---|
| All-time high | $23.2652 (Aug 13, 2025) |
| All-time low | $20.5332 (Oct 22, 2025) |
| 52-week high | $21.8992 |
| 52-week low | $20.5332 |
| Median price | $20.5332 |
| Average price | $20.9406 |
| Largest weekly change | -6.2% (Oct 22, 2025) |
| Weeks tracked | 57 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the temozolomide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 250 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $20.5332 per EA (NDC 16571082151), effective Aug 19, 2026.
How has the price of TEMOZOLOMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has declined 11.7%. It has been tracked across 57 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 250 MG CAPSULE?
Since Jul 23, 2025, the NADAC for TEMOZOLOMIDE 250 MG CAPSULE has ranged from a low of $20.5332 (Oct 22, 2025) to a high of $23.2652 (Aug 13, 2025), with a median of $20.5332 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of TEMOZOLOMIDE 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TEMOZOLOMIDE 250 MG CAPSULE?
TEMOZOLOMIDE 250 MG CAPSULE (NDC 16571082151) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.